MCID: OLV001
MIFTS: 58

Olivopontocerebellar Atrophy malady

Rare diseases, Cardiovascular diseases, Nephrological diseases, Fetal diseases categories

Aliases & Classifications for Olivopontocerebellar Atrophy

About this section
Sources:
9Disease Ontology, 41NIH Rare Diseases, 42NINDS, 43Novoseek, 47Orphanet, 60UMLS, 38NCIt, 55SNOMED-CT, 33MeSH, 34MESH via Orphanet, 26ICD10 via Orphanet, 61UMLS via Orphanet
See all sources

Olivopontocerebellar Atrophy, Aliases & Descriptions:

Name: Olivopontocerebellar Atrophy 9 41 42
Thomas Syndrome 41 47 60
Olivopontocerebellar Atrophies 43 60
Potter Sequence - Cleft Lip/palate - Cardiopathy 47
Olivopontocerebellar Degeneration 9
Spinocerebellar Ataxia Type 1 60
Spinocerebellar Ataxia Type 2 60
 
Spinocerebellar Ataxia 1 9
Dejerine-Thomas Syndrome 9
Spinocerebellar Ataxia 2 9
Wadia-Swami Syndrome 9
Thomas' Syndrome 9
Opca 41


Classifications:



Characteristics (Orphanet epidemiological data):

47
thomas syndrome:
Age of onset: Infancy,Neonatal


External Ids:

Disease Ontology9 DOID:14784
NCIt38 C84947
MeSH33 D009849
Orphanet47 3316
MESH via Orphanet34 C536514
ICD10 via Orphanet26 Q87.8
UMLS via Orphanet61 C2931225

Summaries for Olivopontocerebellar Atrophy

About this section


NIH Rare Diseases:41 Olivopontocerebellar atrophy is a progressive disease that causes areas deep in the brain, just above the spinal cord, to shrink. the main symptom is clumsiness (ataxia) that slowly gets worse. there may also be problems with balance, slurring of speech, and difficulty walking. olivopontocerebellar atrophy can be passed down through families (inherited form), or it may affect people without a known family history (sporadic form). symptoms tend to start at a younger age in people with the inherited form of the condition. there is no specific treatment or cure for this disease. therapy is aimed at treating symptoms and preventing complications. last updated: 2/9/2011

MalaCards based summary: Olivopontocerebellar Atrophy, also known as thomas syndrome, is related to spinocerebellar ataxia 7 and striatonigral degeneration, and has symptoms including multicystic kidney dysplasia, oral cleft and oligohydramnios. An important gene associated with Olivopontocerebellar Atrophy is ATXN2 (ataxin 2), and among its related pathways are Sympathetic Nerve Pathway (Pre- and Post- Ganglionic Junction) and Biogenic Amine Synthesis. The compounds ibotenic acid and d amphetamine have been mentioned in the context of this disorder. Affiliated tissues include brain, cerebellum and pons, and related mouse phenotypes are endocrine/exocrine gland and normal.

Disease Ontology:9 A spinocerebellar ataxia that is characterized by progressive cerebellar ataxia, leading to clumsiness in body movements, veering from midline when walking, wide-based stance, and falls without signs of paralysis or weakness and has material basis in expansion of cag triplet repeats (glutamine) resulting in degeneration of neuron in the cerebellum, pons and inferior olives.

NINDS:42 Olivopontocerebellar atrophy (OPCA) is a term that describes the degeneration of neurons in specific areas of the brain ? the cerebellum, pons, and inferior olives.

Wikipedia:63 Olivopontocerebellar atrophy (OPCA) is the degeneration of neurons in specific areas of the brain ? the... more...

Related Diseases for Olivopontocerebellar Atrophy

About this section

Diseases related to Olivopontocerebellar Atrophy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 106)
idRelated DiseaseScoreTop Affiliating Genes
1spinocerebellar ataxia 730.9ATXN2, ATXN7
2striatonigral degeneration30.9SLC6A3, MAP2, RPS27A
3spinocerebellar ataxia30.7ATXN2
4spinal muscular atrophy30.7MAP1B, CHAT
5spinocerebellar degeneration30.5GLUD1, ATXN2, RPS27A
6pick disease30.5CHAT, RPS27A, MAPT
7machado-joseph disease30.2ATXN7, SLC6A3, ATXN2, RPS27A
8dementia30.2TH, MAP2, CHAT, SLC6A3, RPS27A, TSPO
9multiple system atrophy29.7RPS27A, MAP2, TSPO, CHAT, TH, SLC6A3
10schizophrenia29.1CHAT, MAP2, MBP, SLC6A3, GLUD1, MAP1B
11spinocerebellar ataxia 110.5
12cerebritis10.5
13ataxia10.5
14neuronal intranuclear inclusion disease10.5RPS27A
15ophthalmoplegia10.5ATXN7
16neuronitis10.5
17retinal degeneration10.5
18retinitis10.5
19olivopontocerebellar atrophy deafness10.5
20rem sleep behavior disorder10.4SLC6A3
21neuropathy10.4
22peripheral neuropathy10.4
23spinal muscular atrophy-110.4MAP1B, RPS27A
24spinocerebellar ataxia 210.3
25adrenoleukodystrophy10.3
26muscular atrophy10.3
27myoclonus10.3
28transient cerebral ischemia10.3MAP2, RPS27A
29hereditary ataxia10.3ATXN7, ATXN2
30frontotemporal lobar degeneration with ubiquitin-positive inclusions10.3RPS27A, MAPT
31spinocerebellar ataxia 1210.3ATXN2, ATXN7
32inclusion body myositis10.3MAPT, RPS27A
33semantic dementia10.3MAPT, RPS27A
34temporal lobe epilepsy10.3GABBR1, TSPO, GLUD1
35akinetic mutism10.3MBP
36cerebellar ataxia10.3
37dentatorubro-pallidoluysian atrophy10.3ATXN2
38hyperaldosteronism10.2NPPA, TH
39drug addiction10.2GABBR1, SLC6A3
40rett syndrome10.2CHAT, TH, MAP2
41supranuclear palsy, progressive10.2SLC6A3, MAPT
42alcohol abuse10.2SLC6A3, RPS27A
43tauopathy10.2RPS27A, MAPT
44anxiety disorder10.2SLC6A3, GABBR1, TSPO
45creutzfeldt-jakob disease10.2RPS27A, TSPO, MAPT
46obsessive-compulsive disorder10.2TSPO, SLC6A3
47hyperammonemia multi-gene panels10.2GLUD1, CHAT, TSPO, MAP2
48amnestic disorder10.2TSPO, DYT10, CHAT
49ganglioglioma10.1TH, MAP2
50spinocerebellar ataxia 1710.1ATXN2, SLC6A3, ATXN7

Graphical network of the top 20 diseases related to Olivopontocerebellar Atrophy:



Diseases related to olivopontocerebellar atrophy

Symptoms for Olivopontocerebellar Atrophy

About this section

Symptoms:

 47 (show all 12)
  • cleft lip and palate
  • congenital cardiac anomaly/malformation/cardiopathy
  • agenesis/hypoplasia/aplasia of kidneys
  • multicystic kidney/renal dysplasia
  • autosomal recessive inheritance
  • early death/lethality
  • oligoamnios
  • dolichocephaly/scaphocephaly
  • high forehead
  • hypertelorism
  • downslanted palpebral fissures/anti-mongoloid slanting palpebral fissures
  • hypoplastic left heart/ventricle

HPO human phenotypes related to Olivopontocerebellar Atrophy:

(show all 9)
id Description Frequency HPO Source Accession
1 multicystic kidney dysplasia hallmark (90%) HP:0000003
2 oral cleft hallmark (90%) HP:0000202
3 oligohydramnios hallmark (90%) HP:0001562
4 renal hypoplasia/aplasia hallmark (90%) HP:0008678
5 dolichocephaly typical (50%) HP:0000268
6 hypertelorism typical (50%) HP:0000316
7 high forehead typical (50%) HP:0000348
8 downslanted palpebral fissures typical (50%) HP:0000494
9 hypoplastic left heart typical (50%) HP:0004383

Drugs & Therapeutics for Olivopontocerebellar Atrophy

About this section

Drug clinical trials:

Search ClinicalTrials for Olivopontocerebellar Atrophy

Search NIH Clinical Center for Olivopontocerebellar Atrophy

Genetic Tests for Olivopontocerebellar Atrophy

About this section

Anatomical Context for Olivopontocerebellar Atrophy

About this section

MalaCards organs/tissues related to Olivopontocerebellar Atrophy:

31
Brain, Cerebellum, Pons, Spinal cord, Kidney, Heart, Cortex, Eye, Skin

Animal Models for Olivopontocerebellar Atrophy or affiliated genes

About this section

MGI Mouse Phenotypes related to Olivopontocerebellar Atrophy:

35
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053798.5TH, ATXN2, GNAI2, MAP2, GLUD1, SLC6A3
2MP:00028738.2SLC6A3, MBP, MAPT, CBLN3, CHAT, TH
3MP:00053897.8ATXN7, ATXN2, CHAT, MAP2, MAP1B, GABBR1
4MP:00053787.2TH, ATXN7, ATXN2, GNAI2, CHAT, MAP2
5MP:00053767.0TH, ATXN2, GNAI2, CHAT, MAP1B, GLUD1
6MP:00107686.8GNAI2, ATXN2, ATXN7, TH, CHAT, MAP2
7MP:00053866.5SLC6A3, TH, ATXN7, ATXN2, GNAI2, CHAT
8MP:00036316.5CHAT, GNAI2, ATXN2, ATXN7, TH, CBLN3

Publications for Olivopontocerebellar Atrophy

About this section

Articles related to Olivopontocerebellar Atrophy:

(show top 50)    (show all 182)
idTitleAuthorsYear
1
Olivopontocerebellar atrophy: toward a better nosological definition. (16874757)
2006
2
Autonomic nervous evaluation in the early stages of olivopontocerebellar atrophy. (16289940)
2005
3
Peculiar aspects of reading and writing performances in patients with olivopontocerebellar atrophy. (12027365)
2002
4
Evolution of sporadic olivopontocerebellar atrophy into multiple system atrophy. (10953186)
2000
5
Oxidative injury is present in Purkinje cells in patients with olivopontocerebellar atrophy. (10831770)
2000
6
Olivopontocerebellar atrophy and peripheral neuropathy--Wadia type. (10999111)
1999
7
Early onset cerebellar ataxia with retained tendon reflexes (EOCA) and olivopontocerebellar atrophy (OPCA): a computed tomographic study. (10625898)
1999
8
Vecuronium dose requirement and pupillary response in a patient with olivopontocerebellar atrophy (OPCA). (9836034)
1998
9
Purkinje cells in olivopontocerebellar atrophy and granule cell-type cerebellar degeneration: an immunohistochemical study. (9678515)
1998
10
Olivopontocerebellar atrophy and multiple system atrophy: clinical follow-up of 10 patients studied with PET. (9667610)
1998
11
Neurobehavioral dimensions of olivopontocerebellar atrophy. (9672819)
1998
12
Movement-related cortical potentials and contingent negative variation in olivopontocerebellar atrophy. (9343719)
1997
13
Olivopontocerebellar atrophy leading to recognition of carbohydrate-deficient glycoprotein syndrome type I. (8923302)
1996
14
The relationship of multiple system atrophy to sporadic olivopontocerebellar atrophy and other forms of idiopathic late-onset cerebellar atrophy. (8628452)
1996
15
Familial infantile olivopontocerebellar atrophy. (7575842)
1995
16
A comparison of cerebral blood flow and glucose metabolism in olivopontocerebellar atrophy using PET. (7617196)
1995
17
Striatal dihydroxyphenylalanine decarboxylase and tyrosine hydroxylase protein in idiopathic Parkinson's disease and dominantly inherited olivopontocerebellar atrophy. (7885342)
1995
18
The Purkinje cell in olivopontocerebellar atrophy. A Golgi and immunocytochemical study. (7516051)
1994
19
Brainstem reflexes in patients with olivopontocerebellar atrophy. (7969244)
1994
20
Facial action myoclonus in patients with olivopontocerebellar atrophy. (8196688)
1994
21
Reflex myoclonus in olivopontocerebellar atrophy. (8158179)
1994
22
Inherited syndrome of infantile olivopontocerebellar atrophy, micronodular cirrhosis, and renal tubular microcysts: review of the literature and a report of an additional case. (8256592)
1993
23
Machado-Joseph disease in New England: clinical description and distinction from the olivopontocerebellar atrophies. (1620136)
1992
24
Quinolinic acid catabolism is increased in cerebellum of patients with dominantly inherited olivopontocerebellar atrophy. (1825460)
1991
25
Olivopontocerebellar atrophy of neonatal onset and disialotransferrin developmental deficiency syndrome. (1929507)
1991
26
Argyrophilic ubiquitinated cytoplasmic inclusions of Leu-7-positive glial cells in olivopontocerebellar atrophy (multiple system atrophy). (1723828)
1991
27
Brain amino acid reductions in one family with chromosome 6p-linked dominantly inherited olivopontocerebellar atrophy. (1686387)
1991
28
Nocturnal stridor in olivopontocerebellar atrophy. (2267479)
1990
29
Morphometric studies in dominant olivopontocerebellar atrophy. Comparison of cell losses with amino acid decreases. (2302090)
1990
30
Cytoplasmic argyrophilic inclusions in neurons of pontine nuclei in patients with olivopontocerebellar atrophy: immunohistochemical and ultrastructural studies. (2163181)
1990
31
Olivopontocerebellar atrophy presenting with hemiparkinsonian ocular motor signs. (2144540)
1990
32
Blepharospasm associated with olivopontocerebellar atrophy. (2531169)
1989
33
Olivopontocerebellar atrophy in a large Iakut kinship in eastern Siberia. (2812335)
1989
34
Non-Alzheimer-type pattern of brain cholineacetyltransferase reduction in dominantly inherited olivopontocerebellar atrophy. (2802535)
1989
35
Olivopontocerebellar atrophy. (3195154)
1988
36
Auditory brainstem response patterns in familial and sporadic olivopontocerebellar atrophy. (3224625)
1988
37
Brain choline acetyltransferase reduction in dominantly inherited olivopontocerebellar atrophy. (3477997)
1987
38
Glutamate dehydrogenase and its isozyme activity in olivopontocerebellar atrophy. (3734837)
1986
39
Sensory and motor peripheral neuropathy in olivopontocerebellar atrophy. (3014798)
1986
40
Neuronal loss in the basal nucleus of Meynert in a patient with olivopontocerebellar atrophy. (4013667)
1985
41
Enzymatic analysis of individual posterior root ganglion cells in olivopontocerebellar atrophy, amyotrophic lateral sclerosis and Duchenne muscular dystrophy. (4045497)
1985
42
Reduction of noradrenaline in cerebellum of patients with olivopontocerebellar atrophy. (6707646)
1984
43
Electromyography and nerve conduction study in autosomal dominant olivopontocerebellar atrophy. (6716108)
1984
44
Benzodiazepine receptor binding in cerebellar cortex: observations in olivopontocerebellar atrophy. (6319600)
1984
45
The neuropathology of olivopontocerebellar atrophy. (6388270)
1984
46
Abnormal metabolism of neuroexcitatory amino acids in olivopontocerebellar atrophy. (6149677)
1984
47
Evoked potentials in olivopontocerebellar atrophy. (6847444)
1983
48
Olivopontocerebellar atrophy with velopharyngolaryngeal paralysis: a contribution to the somatotopy of the nucleus ambiguus. (448399)
1979
49
Olivopontocerebellar atrophy in a cat. (21010608)
1946
50
Olivopontocerebellar atrophy (heredocerebellar ataxia of Marie) with encephalographic findings. (20274023)
1946

Variations for Olivopontocerebellar Atrophy

About this section

Clinvar genetic disease variations for Olivopontocerebellar Atrophy:

6
id Gene Variation Type Significance SNP ID Assembly Location
1ATXN2NP_002964.3: p.Gln166(> =33)NT expansionPathogenic

Expression for genes affiliated with Olivopontocerebellar Atrophy

About this section
Search GEO for disease gene expression data for Olivopontocerebellar Atrophy.

Pathways for genes affiliated with Olivopontocerebellar Atrophy

About this section

Pathways related to Olivopontocerebellar Atrophy according to GeneCards Suite gene sharing:

(show all 13)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
110.0TH, CHAT
2
Show member pathways
catecholamine biosynthesis36
10.0CHAT, TH
3
Show member pathways
9.7MAPT, MAP2
49.6TH, CHAT, MAP2
59.6TH, ATXN2, SLC6A3
6
Show member pathways
9.5TH, GNAI2, SLC6A3
79.4MAPT, MAP1B
8
Show member pathways
creatine-phosphate biosynthesis36
glycine degradation (creatine biosynthesis)36
putrescine biosynthesis III36
spermidine biosynthesis I36
tryptophan degradation via kynurenine36
spermine biosynthesis36
urea cycle36
S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation I36
tyrosine degradation I36
L-carnitine biosynthesis36
methylthiopropionate biosynthesis36
2-oxoglutarate decarboxylation to succinyl-CoA36
S-methyl-5-thioadenosine degradation II36
9.4GLUD1, TH, HAAO
9
Show member pathways
9.4SLC6A3, GABBR1, CHAT, GNAI2
10
Show member pathways
9.1TH, GNAI2, CHAT, GABBR1, SLC6A3
11
Show member pathways
9.0TH, ATXN7, GNAI2, NPPA, SLC6A3
128.9GABBR1, GLUD1, MAPT, MAP2, TH

Compounds for genes affiliated with Olivopontocerebellar Atrophy

About this section

Compounds related to Olivopontocerebellar Atrophy according to GeneCards Suite gene sharing:

(show top 50)    (show all 142)
idCompoundScoreTop Affiliating Genes
1ibotenic acid439.9TH, CHAT, SLC6A3
2d amphetamine439.8SLC6A3, TSPO, TH
3gamma-hydroxybutyrate439.8TSPO, GABBR1, GLUD1
4carbidopa43 2810.7TH, NPPA, SLC6A3
56-hydroxydopamine439.7RPS27A, CHAT, TH, SLC6A3
6rotenone439.6TH, SLC6A3, RPS27A, TSPO
7mptp439.6TH, TSPO, RPS27A, SLC6A3
8quisqualate43 1210.5CHAT, MAP2, MAPT
9baclofen43 1210.5SLC6A3, GABBR1, TSPO
10opiate439.5TH, TSPO, SLC6A3, GABBR1
11methamphetamine43 49 1211.4SLC6A3, CHAT, TH, RPS27A, MAP2
12spec-t439.4MAPT, TSPO, NPPA, SLC6A3
135-hydroxytryptamine439.4GABBR1, SLC6A3, TSPO, CHAT, TH
14valproate439.3SLC6A3, GABBR1, GLUD1, MAPT, TH
15morphine43 49 28 1212.3SLC6A3, TH, TSPO, GABBR1, NPPA
16catecholamine439.3CBLN3, TH, NPPA, GABBR1, CHAT
17glycerol43 24 1211.2TSPO, RPS27A, MAPT, GLUD1, NPPA
18valine439.2TSPO, RPS27A, MAPT, GLUD1, SLC6A3
19formaldehyde43 2410.1MAPT, TH, CHAT, RPS27A, MBP
20haloperidol43 49 28 2 1213.1SLC6A3, CHAT, TH, NPPA, TSPO, GLUD1
21sodium dodecylsulfate439.1MBP, NPPA, GLUD1, RPS27A, MAPT
22corticosterone43 59 2411.0MAP2, MBP, TH, TSPO, CBLN3
23nicotine43 28 49 1212.0TH, TSPO, MAP2, MAPT, SLC6A3, CHAT
24polyacrylamide438.8HAAO, ATXN2, MAP1B, ATXN7, GLUD1
25testosterone43 59 24 1211.7CHAT, TSPO, TH, NPPA, MAPT, MAP2
26cyclosporin a43 28 5910.7NPPA, TSPO, RPS27A, MAPT, GLUD1, MBP
27epinephrine43 24 1210.7CBLN3, MBP, NPPA, TH, RPS27A
28cocaine43 129.6CHAT, TSPO, MAP2, GABBR1, MBP, SLC6A3
29kainate43 289.6GABBR1, TH, TSPO, MBP, MAPT, MAP2
30lactate438.6RPS27A, TH, CHAT, MAP2, MAPT, GLUD1
31silver438.6MAP2, RPS27A, CHAT, MAPT, MAP1B, MBP
32choline43 24 1210.5TH, SLC6A3, GLUD1, MAPT, MAP2, CHAT
33glutamine438.5RPS27A, MBP, TH, TSPO, MAPT, ATXN2
34creatinine438.4SLC6A3, NPPA, MBP, GLUD1, MAPT, TSPO
35alanine438.4CHAT, MAPT, GLUD1, MBP, SLC6A3, TH
36forskolin43 49 1210.3CHAT, TH, DYT10, GABBR1, MBP, NPPA
37aspartate438.3GABBR1, GLUD1, MAPT, RPS27A, CHAT, TH
38arginine438.3MBP, TSPO, RPS27A, MAPT, GLUD1, NPPA
39paraffin438.3MAPT, MAP1B, MAP2, RPS27A, CHAT, TH
40estrogen438.2TH, MAP2, MAPT, NPPA, CHAT, TSPO
41dopamine43 28 24 1211.2TSPO, CHAT, TH, NPPA, RPS27A, GABBR1
42acetylcholine43 49 28 24 1212.1RPS27A, TH, CHAT, TSPO, MAPT, GLUD1
43adenylate438.0DYT10, MAP2, RPS27A, MBP, GABBR1, TH
44cyclic amp43 248.9MAP2, CHAT, TH, NPPA, DYT10, GABBR1
45norepinephrine43 24 129.9TSPO, NPPA, SLC6A3, TH, CHAT, CBLN3
46gaba437.6GABBR1, RPS27A, GLUD1, MAP1B, MAP2, CHAT
47threonine437.5MBP, DYT10, MAPT, CHAT, RPS27A, MAP2
48h2o2437.4RPS27A, TSPO, TH, MAP2, MAPT, DYT10
49glutamate436.9DYT10, SLC6A3, MAPT, MAP2, RPS27A, GLUD1
50nmda43 287.8GABBR1, SLC6A3, GLUD1, DYT10, TH, TSPO

GO Terms for genes affiliated with Olivopontocerebellar Atrophy

About this section

Cellular components related to Olivopontocerebellar Atrophy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1nuclear peripheryGO:00343999.6MAPT, MAP2
2microtubule associated complexGO:00058759.2MAP2, MAP1B, MAPT
3axonGO:00304249.2CHAT, MAPT, SLC6A3
4neuronal cell bodyGO:00430259.0CHAT, MAP2, MBP, SLC6A3
5cytosolGO:00058297.9TH, GNAI2, CHAT, RPS27A, MAP1B, MAPT
6cytoplasmGO:00057377.3SLC6A3, TH, ATXN7, ATXN2, GNAI2, CHAT

Biological processes related to Olivopontocerebellar Atrophy according to GeneCards Suite gene sharing:

(show all 13)
idNameGO IDScoreTop Affiliating Genes
1gamma-aminobutyric acid signaling pathwayGO:000721410.1GABBR1, GNAI2
2dopamine biosynthetic processGO:004241610.0SLC6A3, TH
3negative regulation of adenylate cyclase activityGO:000719410.0GNAI2, GABBR1
4neurotransmitter biosynthetic processGO:00421369.8TH, CHAT, SLC6A3
5negative regulation of intracellular transportGO:00323879.7MAPT, MAP1B
6mitochondrion transport along microtubuleGO:00474979.7MAPT, MAP1B
7axon extensionGO:00486759.6MAP1B, MAPT
8microtubule bundle formationGO:00015789.6MAP1B, MAP2
9positive regulation of axon extensionGO:00457739.6MAPT, MAP1B
10cell deathGO:00082199.6SLC6A3, ATXN2, ATXN7
11cellular nitrogen compound metabolic processGO:00346419.4GLUD1, TH, HAAO
12response to zinc ionGO:00100439.4TH, HAAO
13synaptic transmissionGO:00072688.8SLC6A3, MBP, GABBR1, TSPO, CHAT, GNAI2

Molecular functions related to Olivopontocerebellar Atrophy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1dopamine bindingGO:00352409.7TH, SLC6A3
2ferrous iron bindingGO:00081989.4TH, HAAO
3microtubule bindingGO:00080179.1MAPT, MAP1B, MAP2
4protein bindingGO:00055156.7SLC6A3, TH, ATXN7, ATXN2, GNAI2, MAP2

Products for genes affiliated with Olivopontocerebellar Atrophy

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies
  • Proteins
  • Kits and Assays

Sources for Olivopontocerebellar Atrophy

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
33MeSH
34MESH via Orphanet
35MGI
38NCIt
39NDF-RT
42NINDS
43Novoseek
45OMIM
46OMIM via Orphanet
50PubMed
51QIAGEN
56SNOMED-CT via Orphanet
60UMLS
61UMLS via Orphanet